NARG2 anticorps (AA 876-982) (FITC)
-
- Antigène Tous les produits NARG2
- NARG2 (NMDA Receptor Regulated 2 (NARG2))
-
Épitope
- AA 876-982
-
Reactivité
- Humain
-
Hôte
- Lapin
-
Clonalité
- Polyclonal
-
Conjugué
- Cet anticorp NARG2 est conjugé à/à la FITC
- Application
- Veuillez nous consulter SVP
- Réactivité croisée
- Humain
- Purification
- >95%, Protein G purified
- Immunogène
- Recombinant Human Little elongation complex subunit 2 protein (876-982AA)
- Isotype
- IgG
-
-
- Restrictions
- For Research Use only
-
- Format
- Liquid
- Buffer
-
Preservative: 0.03 % Proclin 300
Constituents: 50 % Glycerol, 0.01M PBS, pH 7.4 - Agent conservateur
- ProClin
- Précaution d'utilisation
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Stock
- -20 °C,-80 °C
- Stockage commentaire
- Upon receipt, store at -20°C or -80°C. Avoid repeated freeze.
-
- Antigène
- NARG2 (NMDA Receptor Regulated 2 (NARG2))
- Autre désignation
- ICE2 (NARG2 Produits)
- Synonymes
- anticorps BRCC1, anticorps B230343B06Rik, anticorps interactor of little elongation complex ELL subunit 2, anticorps ICE2, anticorps Ice2
- Sujet
-
Background: Component of the little elongation complex (LEC), a complex required to regulate small nuclear RNA (snRNA) gene transcription by RNA polymerase II and III.
Aliases: ICE2 antibody, BRCC1 antibody, NARG2 antibody, UNQ3101/PRO10100 antibody, Little elongation complex subunit 2 antibody, Interactor of little elongator complex ELL subunit 2 antibody, NMDA receptor-regulated protein 2 antibody
- UniProt
- Q659A1
-